Kevin P. McRaith
Directeur Général chez WellDoc, Inc.
Profil
Kevin P.
McRaith is currently the President, Chief Executive Officer & Director at WellDoc, Inc. Previously, he worked as the Vice President-Sales & Marketing at Genentech, Inc. and as the Vice President-Marketing at Human Genome Sciences, Inc. from 2009 to 2010.
He completed his undergraduate degree at the University of Iowa.
Postes actifs de Kevin P. McRaith
| Sociétés | Poste | Début |
|---|---|---|
WellDoc, Inc.
 WellDoc, Inc. Packaged SoftwareTechnology Services WellDoc, Inc. develops technology solutions to support chronic disease management. Its product DiabetesManager provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence. The company was founded by Ryan Sysko, Yves Nordmann and Suzanne Sysko Clough in 2005 and is headquartered in Columbia, MD. | Directeur Général | 13/01/2015 |
Anciens postes connus de Kevin P. McRaith
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Sales & Marketing | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 11/06/2009 |
Formation de Kevin P. McRaith
| University of Iowa | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
WellDoc, Inc.
WellDoc, Inc. Packaged SoftwareTechnology Services WellDoc, Inc. develops technology solutions to support chronic disease management. Its product DiabetesManager provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence. The company was founded by Ryan Sysko, Yves Nordmann and Suzanne Sysko Clough in 2005 and is headquartered in Columbia, MD. | Technology Services |